» Articles » PMID: 37460960

What Clinic Closure Reveals About Care for Drug-resistant TB: a Qualitative Study

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2023 Jul 17
PMID 37460960
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There have been calls for "person-centered" approaches to drug-resistant tuberculosis (DR-TB) care. In 2020, Charles James Hospital in South Africa, which incorporated person-centered care, was closed. Patients were referred mid-course to a centralized, tertiary hospital, providing an opportunity to examine person-centered DR-TB and HIV care from the perspective of patients who lost access to it.

Methods: The impact of transfer was explored through qualitative interviews performed using standard methods. Analysis involved grounded theory; interviews were assessed for theme and content.

Results: After switching to the centralized site, patients reported being unsatisfied with losing access to a single clinic and pharmacy where DR-TB, HIV and chronic disease care were integrated. Patients also reported a loss of care continuity; at the decentralized site there was a single, familiar clinician whereas the centralized site had multiple, changing clinicians and less satisfactory communication. Additionally, patients reported more disease-related stigma and less respectful treatment, noting the loss of a "special place" for DR-TB treatment.

Conclusion: By focusing on a DR-TB clinic closure, we uncovered aspects of person-centered care that were critical to people living with DR-TB and HIV. These perspectives can inform how care for DR-TB is operationalized to optimize treatment retention and effectiveness.

References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
Ho J, Byrne A, Linh N, Jaramillo E, Fox G . Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bull World Health Organ. 2017; 95(8):584-593. PMC: 5537756. DOI: 10.2471/BLT.17.193375. View

3.
Padayatchi N, Bionghi N, Osman F, Naidu N, Ndjeka N, Master I . Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid. Int J Tuberc Lung Dis. 2020; 24(10):1024-1031. PMC: 8141513. DOI: 10.5588/ijtld.20.0048. View

4.
Bisson G, Bastos M, Campbell J, Bang D, Brust J, Isaakidis P . Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. Lancet. 2020; 396(10248):402-411. PMC: 8094110. DOI: 10.1016/S0140-6736(20)31316-7. View

5.
Brust J, Shah N, Mlisana K, Moodley P, Allana S, Campbell A . Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa. Clin Infect Dis. 2018; 66(8):1246-1253. PMC: 5888963. DOI: 10.1093/cid/cix1125. View